Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Aravax

Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation

Food Allergy Treatment Market Is Set to Triple — What it...

A new era in food allergy treatment has begun

Aravax Testing New Way to Tackle Food Allergy

Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

Promising Food Allergy Treatment from Aravax Receives $12 Million Investment

Aravax Doses First Patient in Phase 2 Peanut Allergy Clinical Trial

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

Follow Us

Your School On Our Map

Put Your School on the Map